Research Programs

The Cancer Institute of New Jersey attracts investigators from a wide range of scientific disciplines to focus on cancer research.

In 2009, the research programs and their membership underwent an internal review in the preparation of the next NCI Cancer Center Support Grant (CCSG) competitive renewal. Based on current research strengths and direction members are now organized into six programs* comprised of faculty who form cohesive, interdisciplinary groups supported by peer-reviewed grants and CINJ shared resources. Programs are organized into three divisions: Basic Science; Clinical Science; and Public Health Science.

(* The current six programs are in development and will be submitted to the NCI for peer-review in the January 2011 CCSG competing renewal. For information about the former research programs, please contact Paul Novembre at Novembre@umdnj.edu).

Translational Team and Program Meetings

Keystone Symposia: Metabolism and Cancer Progression, March 12-17, 2010

Keystone Symposia: Cell Death Pathways: Apoptosis, Autophagy and Necrosis, March 12-17, 2010

Programs

Cell Death and Survival Signaling
Program Leader: Eileen White, PhD

Genomic Instability and Tumor Progression
Program Leaders: Michael Reiss, MD & Zhiyuan Shen, MD, PhD

Cancer Pharmacology
Program Leaders: Leroy F. Liu, PhD & Joseph R. Bertino, MD

Clinical Investigations
Program Leaders: Joseph Aisner, MD, & Susan Goodin, PharmD, BCOP

Carcinogenesis and Chemopreventio
Program Leaders: C. S. Yang, PhD & A-N Tony Kong, PhD

Quality and Outcomes in Cancer Care
Program Leader: Benjamin F. Crabtree, PhD

The Cancer Institute of New Jersey CINJ\|Contact CINJ	Robert Wood Johnson Medical School RWJMS\|Contact RWJMS\|Service Level Agreement	University of Medicine and Dentistry of New Jersey UMDNJ\|Contact UMDNJ
© 2008 Robert Wood Johnson Medical School, all rights reserved.